Companies: 10,795·Total market cap: $144.5T

Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

GALTNASDAQHealthcare● Active

$2.38

+$0.05(+1.93%)

Market Cap$156410133

P/E Ratio—

52W High$7.13

52W Low$1.27

Avg Volume349K

Open$2.35

Beta0.49

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Galectin Therapeutics Inc.（GALT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GALT · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.41Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding63.9MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Galectin Therapeutics Inc. 数据

分析师预测$11 · Buy

股息不分红

盈利EPS $-0.48+36.84%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$30.8M▲ +34.46% YoY

202320242025

FY 2025EPS$-0.48▲ +36.84% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$26.3MEPS: $-0.41View income statement →

分析师评级与目标价

Buy11 位分析师

Strong Buy

0

Buy

9

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$11.00Low

$2.38Current

$11.00Avg Target上涨空间 363.16%

$11.00High

合计: 11 · 买入占比: 81.8%

根据过去 3 个月内 11 位华尔街分析师，GALT 共识评级为 Buy，12 个月平均目标价 $11.00 （较现价 $2.38 上涨空间 363.16%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Galectin Therapeutics Inc.

$2.38+1.93%$156.4M #2

Altimmune, Inc.

$2.75+1.07%$242.3M #3

Aura Biosciences, Inc.

$6.48-2.41%$415.7M #4

DiaMedica Therapeutics Inc.

$5.58+0.71%$300.7M #5

Alpha Tau Medical Ltd.

$9.51+2.03%$859.0M #6

Design Therapeutics, Inc.

$10.30-3.71%$643.0M

股票表现

1D+1.29%

1W-2.88%

1M+12.38%

3M-23.87%

YTD-43.27%

1Y+78.79%

5Y-41.29%

关于 Galectin Therapeutics Inc.

CEOJoel Lewis

IPO DateSep 4, 2002

Employees15

CountryUS

Websitegalectintherapeutics.com

Galectin Therapeutics Inc. a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candid…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Galectin Therapeutics Inc.（GALT）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 4, 2002 在 NASDAQ 上市。截至最近交易日，GALT 股价为 $2.38，市值约为 $155.4M。过去12个月累计回报 +78.79%，年初至今回报 -43.27%。

根据 11 位华尔街分析师，Galectin Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $11.00。2025 财年 Galectin Therapeutics Inc. 营收 —，净利润 -$30.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Galectin Therapeutics Inc.（GALT）股价为 $2.38，在 NASDAQ 上市，52周区间为 $1.27 – $7.13。

GALT 最新股价GALT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议